DR4 (B-9) PE Antibody sc-8411 PE from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

DR4 (B-9) PE Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
DR4 (B-9) PE Antibody

The DR4 (B-9) PE Antibody from Santa Cruz Biotechnology, Inc. is a Mouse Monoclonal antibody to TNFRSF10A. This antibody recognizes Homo Sapiens, and Human antigen. The DR4 (B-9) PE Antibody has been shown to work in the following applications: Flow Cytometry, Immunofluorescence, Immunohistochemistry - fixed, and Western Blot.

Product Specs
ItemDR4 (B-9) PE Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $343.00Supplier Page View Company Product Page
Catalog Numbersc-8411 PE
Antibody TypePrimary Antibody Conjugates
Clonalitymonoclonal
Reactivityhuman
FormatPurified
ApplicationsWB(RGB), IF, IHC(P), FCM
CloneB-9
IsotypeIgG1
Hostmouse
Quantity200 µg/ml
TargetDR4
NCBI Full Gene NameTNF receptor superfamily member 10a
NCBI Gene AliasesTRAILR-1, TRAILR1, APO2, DR4, CD261
Conjugate/Tagphycoerythrin

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Induction of apoptotic cell death in human bladder cancer cells by ethanol extract of Zanthoxylum schinifolium leaf, through ROS-dependent inactivation of the PI3K/Akt signaling pathwayNutrition research and practiceJune 1, 2022Park C, Choi EO, Hwangbo H, Lee H, Jeong JW, Han MH, Moon SK, Yun SJ, Kim WJ, Kim GY, et al.

(2) TRAIL sensitivity of nasopharyngeal cancer cells involves redox dependent upregulation of TMTC2 and its interaction with membrane caspase-3Redox biologyDecember 1, 2021Raman D, Tay P, Hirpara JL, Liu D, Pervaiz S.

(3) Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathwayOncology lettersJune 1, 2021Huang M, Yi C, Huang XZ, Yan J, Wei LJ, Tang WJ, Chen SC, Huang Y.

(4) Proteome Analysis of Human Natural Killer Cell Derived Extracellular Vesicles for Identification of Anticancer EffectorsMolecules (Basel, Switzerland)November 9, 2020Choi JW, Lim S, Kang JH, Hwang SH, Hwang KC, Kim SW, Lee S.

(5) Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathwayActa pharmaceutica (Zagreb, Croatia)June 1, 2020Wang F, Ye X, Zhai D, Dai W, Wu Y, Chen J, Chen W.

(6) CCR4‑NOT transcription complex subunit 2 regulates TRAIL sensitivity in non‑small‑cell lung cancer cells via the STAT3 pathwayInternational journal of molecular medicineFebruary 1, 2020Kim EO, Kang SE, Choi M, Rhee KJ, Yun M.

(7) Anti‑survival and pro‑apoptotic effects of meridianin C derivatives on MV4‑11 human acute myeloid leukemia cellsInternational journal of oncologyJanuary 1, 2020Cho H, Yadav AK, Do Y, Heo M, Bishop-Bailey D, Lee J, Jang BC.

(8) Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levelsJournal of cellular physiologyAugust 1, 2019De Blasio A, Pratelli G, Drago-Ferrante R, Saliba C, Baldacchino S, Grech G, Tesoriere G, Scerri C, Vento R, Di Fiore R.

(9) Apoptosis of cancer cells is triggered by selective crosslinking and inhibition of receptor tyrosine kinasesCommunications biologyJanuary 1, 2019Wang K, Wang X, Hou Y, Zhou H, Mai K, He G.

(10) Pseudomonas aeruginosa quorum-sensing metabolite induces host immune cell death through cell surface lipid domain dissolutionNature microbiologyJanuary 1, 2019Song D, Meng J, Cheng J, Fan Z, Chen P, Ruan H, Tu Z, Kang N, Li N, Xu Y, et al.

(11) Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70Oncology reportsJanuary 1, 2017Zhou Y, Ma J, Zhang J, He L, Gong J, Long C.

(12) β-arrestin2 regulates TRAIL-induced HepG2 cell apoptosis via the Src-extracellular signal-regulated signaling pathwayMolecular medicine reportsJuly 1, 2016Qi Z, Qi S, Gui L, Shen L.

(13) Induction of cell cycle arrest, DNA damage, and apoptosis by nimbolide in human renal cell carcinoma cellsTumour biology : the journal of the International Society for Oncodevelopmental Biology and MedicineSeptember 1, 2015Hsieh YH, Lee CH, Chen HY, Hsieh SC, Lin CL, Tsai JP.

(14) 3,3'-diindolylmethane potentiates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of gastric cancer cellsOncology lettersMay 1, 2015Ye Y, Miao S, Wang Y, Zhou J, Lu R.

(15) Curcumin induces cell apoptosis in human chondrosarcoma through extrinsic death receptor pathwayInternational immunopharmacologyJune 1, 2012Lee HP, Li TM, Tsao JY, Fong YC, Tang CH.

(16) Death receptor 5 signaling promotes hepatocyte lipoapoptosisThe Journal of biological chemistryNovember 11, 2011Cazanave SC, Mott JL, Bronk SF, Werneburg NW, Fingas CD, Meng XW, Finnberg N, El-Deiry WS, Kaufmann SH, Gores GJ.

(17) Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cellsLeukemia researchOctober 1, 2007Yang SH, Chien CM, Lu CM, Chen YL, Chang LS, Lin SR.

(18) MADD/DENN splice variant of the IG20 gene is a negative regulator of caspase-8 activation. Knockdown enhances TRAIL-induced apoptosis of cancer cellsThe Journal of biological chemistryApril 20, 2007Mulherkar N, Prasad KV, Prabhakar BS.

(19) IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISCOncogeneAugust 12, 2004Ramaswamy M, Efimova EV, Martinez O, Mulherkar NU, Singh SP, Prabhakar BS.

(20) Death receptor response in rodent testis after mono-(2-ethylhexyl) phthalate exposureToxicology and applied pharmacologyDecember 1, 2002Giammona CJ, Sawhney P, Chandrasekaran Y, Richburg JH.

Be the First to Write a Review!